Sentences with phrase «for pancreatic cancer research»

Dr. Simeone: What I'd like to see happen is more focus and funds for pancreatic cancer research.

The Pancreatic Cancer Collective will offer funding opportunities for pancreatic cancer research, such as Requests for Applications, Calls for Ideas or other similar mechanisms.

Kerri Kaplan is the President and CEO of the Lustgarten Foundation for Pancreatic Cancer Research, America's largest private foundation dedicated to funding pancreatic cancer research.

This research was supported by the National Institutes of Health, the US Department of Veterans Affairs, and Hirshberg Foundation for Pancreatic Cancer Research.

«This research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study in Nature.

Helmy Eltoukhy, Co-founder and CEO, Guardant Health Dr. Sam Hanash, Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center Dr. Anirban Maitra, Scientific Director, Sheikh Ahmed Center for Pancreatic Cancer Research, MD Anderson Cancer Center Moderator: Clifton Leaf, Fortune

Not exact matches

In response to «Fructose Induces Transketolase Flux to Promote Pancreatic Cancer Growth,» a study published in the journal Cancer Research, Dr. Maureen Storey, senior vice president for science policy for the American Beverage Association, said:

The senior, majoring in biology, who is researching the potential of using the spice turmeric to combat pancreatic cancer, said it was «inspiring» that Biden was pushing for more cancer research.

«New research to combat pancreatic cancer: The research can improve chemotherapy treatments for pancreatic cancer.»

In an abstract titled «Factors Associated with Failure to Operate for Localized Pancreatic Adenocarcinoma,» the research team used the Surveillance, Epidemiology and End Results (SEER) database to identify factors associated with not receiving surgery in patients with localized pancreatPancreatic Adenocarcinoma,» the research team used the Surveillance, Epidemiology and End Results (SEER) database to identify factors associated with not receiving surgery in patients with localized pancreaticpancreatic cancer.

On the other hand, the continuing increase in lung cancer mortality among European women represents a challenge for cancer control, and the steady increase in pancreatic cancer deserves high priority for research.»

Professor Paolo Boffetta (MD), the Annals of Oncology associate editor for epidemiology and Director of the Institute of Translational Epidemiology at the Icahn School of Medicine at Mount Sinai in New York (USA), commented: «These results are extremely important in showing that reducing cancer mortality can be achieved: priority should be given to research in cancers with unfavourable trends, such as pancreatic cancer, and in reducing cancer mortality disparities, both between countries (Central / Eastern versus Western Europe), and within countries, for example, between socioeconomic groups.

Adding two blood - borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer InstCancer Center reports in the Journal of the National Cancer InstCancer Institute.

The development of new treatments for pancreatic cancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a # 10 million investment from Cancer Researcancer is set to be transformed by a network of clinical trials, aiming to find the right trial for the right patient, after a # 10 million investment from Cancer ResearCancer Research UK.

A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania.

«If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,» said Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry.

The current standard of care for advanced pancreatic cancer — a combination of nab - paclitaxel and gemcitabine — was developed by TGen and the HonorHealth Research Institute, and approved by the U.S. Food and Drug Administration in 2013.

In addition to providing a new tool for diagnoses, the research may also lead to new insights into how pancreatic cancer arises.

«Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Lacancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU LaCancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Langone.

Maggie Blanks, Pancreatic Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an eaPancreatic Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early Cancer Research Fund's CEO, said: «It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an eapancreatic cancer at an early cancer at an early stage.

Their work offers the potential to change the way pancreatic cancer research is done, allowing scientists to interrogate the pathways driving this devastating disease while searching for new drug targets.

The research team combined activated platelets primed for the clotting process with three groups of cancer cells: • metastatic colon cancer (cells that have spread outside the colon), • nonmetastatic colon cancer (cells that grow only within the colon) and • nonmetastatic pancreatic cancer cells.

«Researchers discover a potential new therapeutic strategy for pancreatic cancer: Researches have have isolated a subpopulation of cancer - associated fibroblasts, which promote tumour growth.

The research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inresearch team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InstCancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InResearch Excellence (SPORE) grant for pancreatic cancer from the National Cancer pancreatic cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

«Potential pancreatic cancer target challenged: New research finds PDX1 critical for cancer growth, but blocking it may lead to more aggressive tumors.»

Longer term, they want to quickly diagnose additional cancer types, including ovarian and pancreatic cancers, which are fast - spreading and require early detection for a patient to survive, says Goda, who was recently appointed as a chemistry professor at the University of Tokyo but will continue his research with U.C.L.A..

Professor Eleanor Stride, Cancer Research UK scientist at the University of Oxford, said: «We're especially excited about the potential this bubbly drink could have for hard to treat cancers like pancreatic cancer, where survival rates are low and better treatments are urgently nCancer Research UK scientist at the University of Oxford, said: «We're especially excited about the potential this bubbly drink could have for hard to treat cancers like pancreatic cancer, where survival rates are low and better treatments are urgently ncancer, where survival rates are low and better treatments are urgently needed.

For patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may not otherwise be an option, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual MeetiFor patients with locally advanced pancreatic cancer, the combination of chemotherapy and stereotactic ablative radiation (SABR) may be a promising treatment option, ultimately allowing them to undergo surgery that may not otherwise be an option, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th Annual Meetifor Radiation Oncology's (ASTRO's) 56th Annual Meeting.

«To move the needle forward toward prolonged survival and better treatment outcomes, our research team created a combined investigational regimen for patients with locally advanced pancreatic cancer,» said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Comprehensive Cancer Instcancer,» said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Comprehensive Cancer InstCancer Institute.

NCCC's leading pancreatic cancer research experts highlight groundbreaking research projects and clinical trials underway for this challenging cancer, and offer thoughts on what the future holds.

Jeanne Ruesch received the Margaret L. Hodges Leadership Award at the 31st annual Lombardi Gala for her advocacy on behalf of research into pancreatic cancer and other cancers of the GI tract.

The $ 25 million Pancreatic Cancer Collective, funded by the Lustgarten Foundation and Stand Up To Cancer, will accelerate research for pancreatic cancer patients who desperately need better tPancreatic Cancer Collective, funded by the Lustgarten Foundation and Stand Up To Cancer, will accelerate research for pancreatic cancer patients who desperately need better treatCancer Collective, funded by the Lustgarten Foundation and Stand Up To Cancer, will accelerate research for pancreatic cancer patients who desperately need better treatCancer, will accelerate research for pancreatic cancer patients who desperately need better tpancreatic cancer patients who desperately need better treatcancer patients who desperately need better treatments.

Based in Woodbury, N.Y., the Foundation supports research to find a cure for pancreatic cancer, facilitates dialogue within the medical and scientific community, and educates the public about the disease through awareness campaigns and fundraising events.

Together, these leading cancer research organizations will attract new collaborators; improve diagnosis of pancreatic cancer using big data; find new treatments for pancreatic cancer; and support the next generation of pancreatic cancer investigators.

Building on the successful outcomes of their multi-year history, these leading cancer research organizations will inspire new collaborators; improve diagnosis of pancreatic cancer using big data; develop new treatments for pancreatic cancer; and support the next generation of pancreatic cancer investigators.

The first request for applications (RFA) will seek projects focusing on pre-clinical development research to increase the number of innovative and effective therapies to treat pancreatic cancer.

Rieger conducted her research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast, lung, pancreatic and other cancers.

Does the World Pancreatic Cancer Coalition raise money to fund research or other programs, like patient services for pancreatPancreatic Cancer Coalition raise money to fund research or other programs, like patient services for pancreatic cCancer Coalition raise money to fund research or other programs, like patient services for pancreaticpancreatic cancercancer?

The research evidence on breast, colorectal (bowel), pancreatic, endometrial (womb), ovarian, prostate, liver, gallbladder, kidney, bladder, stomach and oesophageal cancers has been updated as part of our Continuous Update Project (CUP); these CUP reports replace the conclusions for these cancers from the Second Expert Report.

The World Pancreatic Cancer Coalition is not a legal entity and does not raise money to fund research or programs for pancreatPancreatic Cancer Coalition is not a legal entity and does not raise money to fund research or programs for pancreatic cCancer Coalition is not a legal entity and does not raise money to fund research or programs for pancreaticpancreatic cancercancer.

About The National Pancreas Foundation Founded in 1997, the National Pancreas Foundation provides hope for those suffering from pancreatitis and pancreatic cancer through funding cutting - edge research, advocating for new and better therapies and providing support and education for patients, caregivers and healthcare professionals.

We are keenly dependent on biostatisticians for ensuring that our clinical trials yield useful information for future generations of patients,» says Maitra, who is the scientific director for the Sheikh Ahmed Pancreatic Cancer Research Center.

Dr. Kozloff's clinical research focuses on new drug developments for colorectal, pancreatic and lung cancer.

Tsien himself explains his motivation for cancer research with the fact that his father died of pancreatic cancer.

The team used pancreatic organoid technology developed in the lab of Professor David Tuveson, Director of CSHL's Cancer Center and Director of Research for the Lustgarten Foundation.

Wang presented results of the new study, which investigated the associations between antihypertensive medications, a receptor known as sRAGE, and pancreatic cancer at the American Association for Cancer Research Annual Meeting (AACR), held April 14 — 18 in Chcancer at the American Association for Cancer Research Annual Meeting (AACR), held April 14 — 18 in ChCancer Research Annual Meeting (AACR), held April 14 — 18 in Chicago.

But Christine was also in the right place at Rhode Island Hospital because our Lifespan Cancer Institute has done remarkable research that has led to promising treatments for pancreatic cancer patCancer Institute has done remarkable research that has led to promising treatments for pancreatic cancer patcancer patients.

Two years post-launch, we've seen an increase in funding for research into lung, pancreatic and oesophageal cancers and brain tumours — together totalling # 74.7 million in 2015/16.

MD Anderson's Institute for Applied Cancer Science (IACS) in combination with Deerfield will provide drug discovery and development expertise, together with translational research focused at advancing autophagy therapeutics into trials in melanoma, lung and pancreatic cancers.

This page features information on pancreatic cancer and immunotherapy clinical trials for pancreatic cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to pancreatic cancer patcancer and immunotherapy clinical trials for pancreatic cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to pancreatic cancer patcancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to pancreatic cancer patCancer Research Institute's role in working to bring effective immune - based cancer treatments to pancreatic cancer patcancer treatments to pancreatic cancer patcancer patients.